NEW YORK (GenomeWeb) ― At least five companies have indicated they will pursue or are considering pursuing Emergency Use Authorization from the US Food and Drug Administration to make nucleic acid tests for Ebola available, while three RT-PCR assays have already been granted EUA since an emergency was declared in early August.

The three real-time RT-PCR tests that have already been granted EUA ― one from the US Department of Defense, and two from the US Centers of Disease Control ― can now be legally used to diagnose patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.